DiscoverThe ASCO Post PodcastCOVID-19: Infection Rate Among Patients Undergoing Anticancer Therapy and Its Effect on Cancer Clinical Trials
COVID-19: Infection Rate Among Patients Undergoing Anticancer Therapy and Its Effect on Cancer Clinical Trials

COVID-19: Infection Rate Among Patients Undergoing Anticancer Therapy and Its Effect on Cancer Clinical Trials

Update: 2023-07-12
Share

Description

<span data-sheets-value= "{"1":2,"2":"

As COVID-19 infection rates again spike around the nation, this week, we’re looking at two recent studies focused on COVID-19 and cancer. The first describes the rate of infection with the virus among asymptomatic patients with cancer undergoing active treatment for their solid tumors. The second explores how the ongoing pandemic is affecting the way patients with cancer choose to participate in clinical trials.

Coverage of stories discussed this week on ascopost.com:

Serial COVID-19 Screening in Asymptomatic Patients Receiving Treatment for Cancer

Survey Finds Patients With Cancer May Be Less Likely to Enroll in Clinical Trials During the COVID-19 Pandemic

To listen to more podcasts from ASCO, visit asco.org/podcasts.



"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> As COVID-19 infection rates again spike around the nation, this week, we’re looking at two recent studies focused on COVID-19 and cancer. The first describes the rate of infection with the virus among asymptomatic patients with cancer undergoing active treatment for their solid tumors. The second explores how the ongoing pandemic is affecting the way patients with cancer choose to participate in clinical trials.

<span data-sheets-value= "{"1":2,"2":"

As COVID-19 infection rates again spike around the nation, this week, we’re looking at two recent studies focused on COVID-19 and cancer. The first describes the rate of infection with the virus among asymptomatic patients with cancer undergoing active treatment for their solid tumors. The second explores how the ongoing pandemic is affecting the way patients with cancer choose to participate in clinical trials.

Coverage of stories discussed this week on ascopost.com:

Serial COVID-19 Screening in Asymptomatic Patients Receiving Treatment for Cancer

Survey Finds Patients With Cancer May Be Less Likely to Enroll in Clinical Trials During the COVID-19 Pandemic

To listen to more podcasts from ASCO, visit asco.org/podcasts.



"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> Coverage of stories discussed this week on ascopost.com:

<span data-sheets-value= "{"1":2,"2":"

As COVID-19 infection rates again spike around the nation, this week, we’re looking at two recent studies focused on COVID-19 and cancer. The first describes the rate of infection with the virus among asymptomatic patients with cancer undergoing active treatment for their solid tumors. The second explores how the ongoing pandemic is affecting the way patients with cancer choose to participate in clinical trials.

Coverage of stories discussed this week on ascopost.com:

Serial COVID-19 Screening in Asymptomatic Patients Receiving Treatment for Cancer

Survey Finds Patients With Cancer May Be Less Likely to Enroll in Clinical Trials During the COVID-19 Pandemic

To listen to more podcasts from ASCO, visit asco.org/podcasts.



"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> Serial COVID-19 Screening in Asymptomatic Patients Receiving Treatment for Cancer

<span data-sheets-value= "{"1":2,"2":"

As COVID-19 infection rates again spike around the nation, this week, we’re looking at two recent studies focused on COVID-19 and cancer. The first describes the rate of infection with the virus among asymptomatic patients with cancer undergoing active treatment for their solid tumors. The second explores how the ongoing pandemic is affecting the way patients with cancer choose to participate in clinical trials.

Coverage of stories discussed this week on ascopost.com:

Serial COVID-19 Screening in Asymptomatic Patients Receiving Treatment for Cancer

Survey Finds Patients With Cancer May Be Less Likely to Enroll in Clinical Trials During the COVID-19 Pandemic

To listen to more podcasts from ASCO, visit asco.org/podcasts.



"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> Survey Finds Patients With Cancer May Be Less Likely to Enroll in Clinical Trials During the COVID-19 Pandemic

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

COVID-19: Infection Rate Among Patients Undergoing Anticancer Therapy and Its Effect on Cancer Clinical Trials

COVID-19: Infection Rate Among Patients Undergoing Anticancer Therapy and Its Effect on Cancer Clinical Trials

The ASCO Post